Healthcommunities.com
Home Search SiteMap Forum Store Physician Board

Leukemia


Chemotherapy - Acute Lymphocytic Leukemia

Physician-developed and -monitored.

Original Date of Publication: 15 Aug 1999
Reviewed by: Stanley J. Swierzewski, III, M.D.
Last Reviewed: 04 Dec 2007

Original Source: http://www.oncologychannel.com/leukemias/chemotherapy-ALL.shtml

Home » Leukemia » Chemotherapy - Acute Lymphocytic Leukemia


Facebook Twitter

Chemotherapy - Acute Lymphocytic Leukemia (ALL)

Chemotherapy for ALL usually begins with a three-drug schedule such as:

Option 1: Chemotherapy with prednisone, vincristine sulfate (Oncovin®), and an anthracycline drug (e.g., daunorubicin)

  • How is it given: Prednisone is given orally in three divided doses, and Vincristine is given intravenously (IV), the drug is delivered into the veins.
  • What is the duration: Prednisone and vincristine are given at weekly intervals for 4 weeks
  • What are the side effects: Vincristine - hair loss, nervous system effects

Option 2: Chemotherapy with prednisone. vincristine (Oncovin ®), and L-asparaginase (Elspar®) or cyclophosphamide (Neosar®)

  • How is it given:
    • Prednisone: orally
    • Vincristine: Intravenously (IV), the drug is delivered into the veins
    • L-asparaginase: IV or intramuscularly; subcutaneously, injected under the skin; or IV (least favorable due to allergic reactions with this route)
    • Cyclophosphamide: IV or orally
  • What is the duration: Prednisone and vincristine are given at weekly intervals for 4 weeks; the schedule for L-asparaginase is more variable. Cyclophosphamide is given every 2 to 5 days, or by another schedule.
  • What are the side effects:
    • Prednisone - immune system effects
    • Vincristine - hair loss, nervous system effects
    • L-asparaginase - anaphylactic (severe allergic) reactions, pancreas inflammation, blood clotting problems
    • Cyclophosphamide - infertility, severe bladder inflammation, cardiotoxicity (heart damage), immune system suppression, hair loss



Consolidation therapy for ALL (1-3 months in adults; 4-8 months in children) may involve treatment with combination chemotherapy or antimetabolites such as methotrexate and 6-mercaptopurine (6-MP):

Option 1: Chemotherapy with prednisone, vincristine (Oncovin®), L-asparaginase (Elspar®) and daunorubicin, followed by Cyclophosphamide (Neosar®), cytarabine (ara-C; Cytosar-U®), and 6-thioguanine (Tabloid®)

Option 2: Chemotherapy with methotrexate sodium plus 6-mercaptopurine (6-MP; Purinethol®)


Facebook Twitter

© 1998-2009 Healthcommunities.com, Inc. All Rights Reserved.



Leukemia (continued...)

Comment on the above article

Browser Comments
    There are currently no comments.

Leukemia Resources

Questions to Ask Your Doctor About Your Cancer

The more knowledge you have, the easier it is to make decisions about your cancer treatment. Print this free handout to take with you on your next office visit.


Join Our Leukemia Forum

Do you have a question, want to share medical advice, or just need to discuss your situation with someone else having a similar experience?

The healthchannels forum is a resource for everyone to share and discuss their health and medical needs with others.

Living with...Share your story

Do you have a personal health story that you would like to share with others?

As a source of free patient education, our goal is to provide our users with trustworthy information and support from others. That's why we've started our "Living with..." sections.

Our "Living With..." support pages are a place to share experiences about living with a certain condition, disease, disorder, or illness and for loved ones of those dealing with health-related issues.

Many people, especially when newly diagnosed, find comfort in knowing that others are having a similar experience.

Help others by sharing your story.

View stories already submitted.

National Cancer Survivors Day is June 7, 2009

To quickly access health information from your website's browser,
download Healthcommunities.com's healthchannels toolbar.